Jiahao Sun

Title: Jiahao Sun: Innovator in Recombinant Viral Vectors

Introduction

Jiahao Sun is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viral vectors. His innovative work aims to enhance immune responses, especially in the context of vaccines.

Latest Patents

Jiahao Sun holds a patent for a recombinant viral vector, an immune composition containing the same, and its use. The patent describes a recombinant viral vector that includes a polynucleotide encoding a fusion peptide of CD4 helper T cell epitopes. This epitope fusion peptide comprises a cytomegalovirus epitope and/or an influenza virus epitope. The invention aims to improve the level of cellular immune response to target immunogens, particularly weak immunogens, and to overcome immune tolerance to antigens, especially tumor antigens or infection-related antigens. The products derived from this invention are designed to enhance the efficacy of vaccines.

Career Highlights

Jiahao Sun is associated with Vacdiagn Biotechnology Co., Ltd., where he continues to push the boundaries of immunological research. His work is pivotal in developing new strategies for vaccine enhancement and immune response modulation.

Collaborations

Jiahao collaborates with notable colleagues, including Jianqing Xu and Yang Huang, who contribute to his research endeavors and innovations.

Conclusion

Jiahao Sun's contributions to the field of biotechnology, particularly through his patent on recombinant viral vectors, highlight his role as an innovator dedicated to improving vaccine efficacy and immune responses. His work continues to pave the way for advancements in immunology and vaccine development.